Rangering i aksjer
#33384
Established in 1993 and headquartered in Teltow, Germany, co.don AG operates as... Established in 1993 and headquartered in Teltow, Germany, co.don AG operates as a global biopharmaceutical firm dedicated to the research, development, and marketing of cell-based pharmaceutical solutions. The company's core focus is on joint preservation and the regenerative repair of articular cartilage defects. Its offerings include Spherox, an advanced three-dimensional chondrocyte product specifically designed to address cartilage damage in adult knee joints. Additionally, co.don AG provides co.don chondrosphere, a therapy utilized for treating cartilage imperfections in younger patients across multiple joints, such as the hip, ankle, shoulder, elbow, and knees. These specialized treatments are primarily employed by orthopedic and trauma surgeons.
Aksjekurs
$0.29060802
Sist synkronisert: 2022-09-30
Pris CNW pris med markedsverdi på B
Markedsverdi av Co.don AG(CNW)
Markedsverdi: $7.77M
Per August 2026 har Co.don AG en markedsverdi på $7.77M. Dette gjør Co.don AG til det 33384th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Co.don AG fra 2001 til 2026
CNW sammenlignet med topp 5 mest populære stocks
| Pris på CNW |
|
Eiendel B |
Markedsverdi for B |
Resultater |
|
|
|
|
$5.452T
|
+70,198,697.41%
|
|
|
|
|
$4.490T
|
+57,813,851.41%
|
|
|
|
|
$4.162T
|
+53,595,471.52%
|
|
|
|
|
$3.676T
|
+47,336,855.10%
|
|
|
|
|
$2.833T
|
+36,478,441.86%
|
